Asthma Exacerbation: Step-by-Step Emergency Therapy

Acute asthma exacerbation is one of the most common respiratory emergencies in the emergency department and the prehospital setting. Rapid severity assessment and consistent escalation of therapy can make the difference between uncomplicated stabilization and a life-threatening course. Precisely because the majority of asthma exacerbations respond well to initial therapy, there is a risk of underestimating severe cases. This article guides you through systematic severity assessment and stepwise therapy – from inhaled bronchodilation to epinephrine and considerations for invasive mechanical ventilation.

Pathophysiology in a Nutshell

Understanding the underlying mechanisms is essential to rationally justify therapeutic decisions. During an acute exacerbation, three pathological processes occur simultaneously:

• Bronchospasm: Contraction of bronchial smooth muscle, leading to airway obstruction within minutes – this is where beta-2 agonists target.
• Mucosal edema: Inflammatory swelling of the bronchial mucosa due to mediator release – the target of systemic glucocorticoid therapy.
• Mucus hypersecretion: Thick mucus additionally obstructs the airways and can become the primary problem in prolonged cases.

The resulting dynamic hyperinflation (air trapping) massively increases the work of breathing, can generate intrinsic PEEP (auto-PEEP), and in extreme cases can compromise venous return to the heart – with consequent circulatory failure.

Severity Assessment

Correct initial assessment determines further management. In clinical practice, a pragmatic three-tier classification has proven effective: mild to moderate, severe, and life-threatening. The transitions are fluid, which is why repeated reassessment is mandatory.

Mild to Moderate Exacerbation

• Able to speak in complete sentences
• Respiratory rate elevated but < 25/min
• Heart rate < 110/min
• SpO₂ ≥ 92%
• PEF > 50% of predicted or personal best
• No use of accessory muscles of respiration

Severe Exacerbation

• Able to speak only in single words or short phrases
• Respiratory rate ≥ 25/min
• Heart rate ≥ 110/min
• SpO₂ < 92%
• PEF 25–50% of predicted
• Use of accessory muscles, sitting upright, inability to lie flat

Life-Threatening Exacerbation (Near-Fatal Asthma)

• "Silent chest": Absent breath sounds despite respiratory effort – an ominous sign
• Cyanosis
• Exhaustion, altered consciousness, confusion
• Bradycardia or hypotension
• SpO₂ < 85%
• PEF < 25% of predicted or not measurable
• Arterial blood gas analysis: normo- or hypercapnia (pCO₂ ≥ 40 mmHg is an alarm sign, as patients with severe obstruction are typically hypocapnic initially)

Key point: A normal pCO₂ during an acute asthma exacerbation is not a sign of stabilization but rather indicates incipient respiratory exhaustion. A rising pCO₂ signals immediate danger to life.

Stepwise Therapy Overview

Therapy for acute asthma exacerbation follows an escalating approach. Each step builds on the previous one – treatments are added, not replaced. Reassessment should occur after each intervention step, ideally every 15–20 minutes.

Step 1: Oxygen and Inhaled Beta-2 Agonists

Oxygen is the first intervention in any symptomatic exacerbation. The target SpO₂ is 93–95% (in adults). Overcorrection to 100% is not necessary and may be harmful in patients with a concomitant COPD component.

Salbutamol is the first-line beta-2 agonist:

• Nebulizer: 2.5–5 mg in 2–3 ml normal saline (0.9%), for severe exacerbation continuous nebulization at 5–10 mg/h via oxygen (6–8 L/min flow rate)
• Metered-dose inhaler (MDI) with spacer: 4–8 puffs of 100 µg each (equivalent to 400–800 µg), repeatable every 15–20 minutes. For mild to moderate exacerbation, the MDI-spacer combination is equivalent to nebulization in terms of bronchodilation
• If inadequate response within 15–20 minutes: repeat and escalate to the next step

Practical tip: In the emergency setting with severe symptoms, the nebulizer is often more pragmatic, as patient cooperation for correct MDI-spacer technique is lacking.

Step 2: Ipratropium Bromide

Ipratropium bromide, an anticholinergic, is added when there is absent or insufficient improvement after initial salbutamol. It provides additive bronchodilation via a different mechanism (muscarinic receptor blockade).

• Nebulizer: 0.5 mg (500 µg) nebulized together with salbutamol
• Metered-dose inhaler with spacer: 4 puffs of 20 µg each (80 µg)
• Repeat: Every 4–6 hours, during the acute phase also every 20 minutes for a total of 3 doses

The combination of salbutamol + ipratropium in the acute phase demonstrates better bronchodilation and reduces hospitalization rates compared to salbutamol alone – particularly in severe cases.

Step 3: Systemic Glucocorticosteroids

Systemic steroids are not an optional add-on but an integral part of therapy for any asthma exacerbation that requires treatment beyond a single salbutamol administration. They target the inflammatory component, with an onset of action of 4–6 hours – making early initiation crucial.

• Prednisolone: 40–50 mg orally (if the patient can swallow) or
• Methylprednisolone: 40–125 mg IV or
• Hydrocortisone: 200 mg IV bolus, then 100 mg every 6 hours

Oral administration is equivalent to intravenous when absorption is intact. Treatment duration is typically 5–7 days; tapering is not required for this short duration.

Step 4: Magnesium Sulfate

Magnesium sulfate is a potent bronchodilator that works by inhibiting calcium influx into smooth muscle cells. It is indicated for severe exacerbation with inadequate response to previous therapy.

• Intravenous: 2 g (8 mmol) MgSO₄ in 100 ml normal saline (0.9%) infused over 20 minutes
• Single dose; routine repeat administration is not recommended
• Monitoring: Blood pressure checks (magnesium can cause hypotension), reflex assessment with repeated dosing

Nebulized: Isotonic magnesium sulfate (150 mg = 0.6 ml of a 25% solution, made up to 3 ml with normal saline 0.9%) as a carrier for salbutamol has shown additive benefit in some studies but is not universally recommended.

Contraindications: Renal insufficiency (relative contraindication – close monitoring required), myasthenia gravis.

Step 5: Epinephrine

Epinephrine is used in life-threatening exacerbation, particularly when an anaphylactic component cannot be reliably excluded or when inhaled therapy can no longer effectively reach the lower airways due to minimal airflow.

• Intramuscular: 0.3–0.5 mg (300–500 µg) of a 1:1,000 solution (1 mg/ml) into the lateral thigh – especially when anaphylaxis-triggered bronchoconstriction is suspected
• Intravenous: 10–20 µg as a bolus (e.g., 0.1–0.2 ml of a 1:10,000 solution, or dilute 1 ml of the 1 mg/ml ampoule in 100 ml normal saline 0.9% and administer in a titrated fashion), then continuous infusion: 0.05–0.5 µg/kg/min titrated to effect
• Nebulized: 2–5 mg epinephrine (2–5 ml of a 1:1,000 solution) via nebulizer – as bridging therapy or when IV access has not yet been established

Caution: Intravenous administration of epinephrine mandates continuous monitoring (ECG, invasive or frequent non-invasive blood pressure measurement). Arrhythmias and hypertensive crises are potential complications.

Step 6: Ketamine and Consideration of Invasive Ventilation

Ketamine possesses bronchodilatory properties and is used in emergency medicine for refractory status asthmaticus:

• Dosing as bronchodilator: 0.1–0.3 mg/kg IV bolus, then if needed 0.5–1 mg/kg/h as continuous infusion
• For induction of anesthesia (RSI): 1–2 mg/kg IV – ketamine is the induction agent of choice for status asthmaticus requiring intubation

Invasive mechanical ventilation is the last resort and carries significant risks:

• Indication: exhaustion, loss of consciousness, respiratory arrest, refractory hypoxemia or hypercapnia with respiratory acidosis
• RSI sequence: Ketamine 1–2 mg/kg + rocuronium 1.2 mg/kg IV
• Ventilator settings: Low respiratory rate (8–10/min), low tidal volume (6–8 ml/kg IBW), prolonged expiratory time (I:E = 1:3 to 1:5), tolerated hypercapnia (permissive hypercapnia, target pH > 7.20)
• Caution: Avoid auto-PEEP! Adequate expiratory time is critical for survival. Circulatory collapse after intubation is frequently caused by air trapping with consequent reduction in cardiac preload

Practical tip: Before intubation: administer a fluid bolus (500–1,000 ml crystalloid) to prevent post-intubation hypotension. In an absolute emergency, manual decompression by disconnecting the patient from the ventilator and applying manual pressure to the thorax (passive exhalation) can be life-saving.

Additional Therapeutic Options

Theophylline

Theophylline has a very limited role in acute therapy. Current evidence shows no additional benefit in patients already adequately treated with beta-2 agonists and ipratropium, while having a narrow therapeutic window and relevant side effects (tachycardia, nausea, seizures). It should only be considered in exceptional cases and with serum level monitoring.

• Dosing (if used): Loading dose 5 mg/kg IV over 20 minutes, then 0.5–0.7 mg/kg/h as continuous infusion
• Target serum level: 10–15 mg/L
• No loading dose in patients on chronic theophylline therapy!

Non-Invasive Ventilation (NIV)

NIV can be considered as bridge therapy in severe exacerbation to avoid intubation. The evidence base is less robust than for COPD exacerbation, but clinical practice frequently shows benefit:

• BiPAP: IPAP 10–15 cmH₂O, EPAP 5 cmH₂O, titrated to comfort and work of breathing
• Close reassessment within 30–60 minutes
• Clearly define discontinuation criteria: lack of improvement, increasing exhaustion, declining level of consciousness

Don't Forget the Differential Diagnoses

Not all wheezing is asthma. Especially in the emergency setting, it is crucial to actively consider the most important differential diagnoses:

• COPD exacerbation (smoking history, age, irreversible obstruction)
• Anaphylaxis (urticaria, angioedema, circulatory involvement – intramuscular epinephrine as first-line therapy!)
• Vocal cord dysfunction (inspiratory stridor, lack of improvement with bronchodilators)
• Pneumothorax (unilaterally decreased breath sounds – ultrasound/chest X-ray!)
• Foreign body aspiration (sudden onset, unilateral findings)
• Acute pulmonary edema (cardiac history, bilateral basal crackles, orthopnea)
• Pulmonary embolism (tachycardia, risk factors, D-dimer, CT angiography)

Algorithm at a Glance

1. Oxygen → Target SpO₂ 93–95%
2. Salbutamol 2.5–5 mg nebulized or 4–8 puffs MDI + spacer → reassess after 15–20 min
3. + Ipratropium bromide 0.5 mg nebulized → if inadequate response
4. + Prednisolone 40–50 mg orally or methylprednisolone 40–125 mg IV → early, always
5. + Magnesium sulfate 2 g IV over 20 min → for severe exacerbation without improvement
6. + Epinephrine IV titrated or IM → life-threatening exacerbation
7. Ketamine as bronchodilator or for induction of anesthesia → refractory course
8. Invasive ventilation with lung-protective strategy and permissive hypercapnia → last resort

In parallel at every step: Repeated clinical reassessment, monitoring of SpO₂, respiratory rate, heart rate, and – in severe cases – arterial blood gas analysis.

Common Mistakes in Practice

• Delayed steroid administration: Steroids take hours to work. Delaying them means losing valuable time.
• Underdosing of salbutamol: In an emergency, generous dosing is appropriate and necessary. 4 puffs of salbutamol via spacer for status asthmaticus is insufficient.
• Neglecting reassessment: The initial assessment can be misleading. Close monitoring is mandatory.
• Fear of epinephrine: In life-threatening exacerbation and/or suspected anaphylactic trigger, epinephrine is life-saving and must not be withheld.
• Post-intubation circulatory collapse: Frequently caused by aggressive ventilation with too high a respiratory rate and too short an expiratory time. The first intervention is to disconnect the patient from the ventilator and allow passive exhalation.

Practical Training

Management of severe asthma exacerbation is a time-critical scenario that requires a structured approach, team communication, and confident decision-making. In an ACLS refresher course at Simulation Tirol, you can train exactly these algorithms in realistic simulation scenarios – from escalating airway management to post-intubation circulatory stabilization. Find more information at ACLS Refresher.

---